Clinical Trials Browser

Phase 2 × Neoplasms × 3-Iodobenzylguanidine × Clear all

NCT03561259 2023-02-16

OPTIMUM

Phase 2 Unknown

Neoplasms, Neuroblastoma, Neuroectodermal Tumors

NCT01413503 2018-09-18

A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors

Phase 2 Completed

50 enrolled 7 charts

Neoplasms, Paraganglioma, Pheochromocytoma, Recurrence